Two research teams presented similar studies at an Alzheimer's disease conference regarding the changes in the brain and cognition of postmenopausal women. Women with self-reported cognition worries showed increased volume in certain brain regions, according to an American study. Meanwhile, an Australian team analyzed MRI images and PET scans with investigational amyloid imaging agent florbetaben collected from 26 female participants. The findings highlight changes in the patients' brains over time and suggest a trend toward greater odds of developing Alzheimer's disease among those with intermediate uptake of the agent.

Related Summaries